METASTATIC SOLID TUMOR
Clinical trials for METASTATIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for METASTATIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug trial halted early: what it means for patients
Disease control TerminatedThis early-stage study tested a new drug called DCC-3116, alone or with other targeted therapies, in people with advanced solid tumors that have certain gene mutations (RAS/MAPK pathway). The trial was terminated early, so results are limited. It involved 91 participants and aime…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
Cancer drug combo study halted early after only 6 patients
Disease control TerminatedThis study tested a new drug (PRT3789) combined with an immunotherapy (pembrolizumab) in people with advanced solid tumors that have a specific genetic change called SMARCA4 mutation. The goal was to see if the combination was safe and could shrink tumors. The study was terminate…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE2 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
Cancer drug trial halted early: PRT7732 studied for rare gene mutation
Disease control TerminatedThis early-stage study tested an experimental oral drug called PRT7732 in people with advanced solid tumors (like lung or stomach cancer) that have a specific genetic change called SMARCA4. The main goals were to check safety, find the right dose, and see if the drug shrinks tumo…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New combo therapy tackles Hard-to-Treat cancers
Disease control TerminatedThis early-stage study tested a new drug called BGB-A3055, alone or with another drug (tislelizumab), in people with advanced or metastatic solid tumors. The goal was to check safety, how the body handles the drug, and any early signs of tumor shrinkage. The study was stopped ear…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Experimental cancer drug trial halted early
Disease control TerminatedThis study tested an experimental drug called TransCon TLR7/8 Agonist, given as an injection into tumors, either alone or with another drug (pembrolizumab). It aimed to find a safe dose and check for side effects in people with advanced solid tumors that had stopped responding to…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Ascendis Pharma Oncology Division A/S • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Cancer drug study halted early: what we know
Disease control TerminatedThis early-stage study tested a new drug, BGB-B3227, alone or with another drug (tislelizumab) in 35 people with advanced solid tumors. The goal was to check safety and find the right dose. The study was terminated early, so results are limited.
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated May 11, 2026 20:47 UTC